Medical Health & Life Science Research News

Research report explores the Global proton therapy market forecast to 2022

Medical Market Research

The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. It is anticipated that the Global proton therapy market will almost double by 2022 from its current market value.

The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment. The number of proton therapy centers worldwide is anticipated to increase year on year, which in turn, will result in more clinical research, better clinician understanding and greater patient awareness of its benefits-which will help drive the further growth.
Download PDF Brochure @…mp;utm_medium=KMI

Globally, the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions. The number of proton therapy centers is increasing globally.

Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market. IBA dominates the proton therapy market globally.

However, other players like Varian, Mitsubishi, Mevion, Hitachi. have also started to make their presence felt in the market.

The United States accounts for maximum share of the proton therapy market. United States is likely to maintain its dominant position throughout the forecasting period.

The US retains the highest number of proton therapy centers and many are in development phase or under construction. 

Asia proton therapy market is anticipated to almost three-fold during the period 2016 - 2022. Asia accounts for around 60% of the world population and half the global burden of cancer.

The incidence of cancer cases is estimated to increase to XX Million in 2030, due to ageing and growing population, lifestyle and socioeconomic changes. Hence, Asian region represents huge market opportunity for proton therapy.

Japan is the leading market for proton therapy in Asia, while, China has the huge market opportunity for proton therapy treatment owing to large population base of cancer patients. 

The European proton therapy market almost tripled to US$ XX Million in 2016 from 2010 level. Proton therapy is currently being used in the Europe for solid tumors in the body particularly, brain, spine, prostate and stomach.

European countries are planning a rapid increase in their proton beam therapy provision in the next few years; Germany, Italy, Sweden and France are all setting up new centers. The European proton therapy market is likely to grow with double digit CAGR during the period 2017 - 2022.

This is the 5th edition report on Proton Therapy Market by iGATE RESEARCH. The report titled “Global Proton Therapy Market (28 Countries Analysis), Patients Treated, List of Proton Therapy Centers, Start of Treatment, Specifications & Company Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. 

Download PDF Brochure @…mp;utm_medium=KMI

News From

Key Market InsightsKey Market Insights
Category: Market Research Publishers and RetailersCompany about: Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns. Our online stage,, offers an unmatched gathering of market examination reports, organization audits, databooks, articles, periodical distributions, databases, on-line endorser administrations, and a great deal m ...
This email address is being protected from spambots. You need JavaScript enabled to view it.